Quarterly Results • Search Archive
Jubilant Pharmova Limited
Results, Financials & Updates
Follow Jubilant Pharmova Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.
1 published deep dive
1 quarter 1 sector
Company Overview
Jubilant Pharmova Limited: latest results and financials
About the business in Nivata's latest coverage
Jubilant Pharmova Limited is a global pharmaceutical and life sciences company operating across multiple specialized business verticals, including Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing Organisation (CDMO) for sterile injectables, Contract Research, Development and Manufacturing Organisation (CRDMO), Generics, and Proprietary Novel Drugs. The company serves global markets, particularly North America, Europe, and other international jurisdictions, delivering critical diagnostic and therapeutic radiopharmaceuticals, allergy relief treatments, and advanced contract manufacturing and research services.
Quarter history
Jubilant Pharmova Limited Results & Financials
Latest Nivata coverage: Q1 FY27 · revenue ₹2,229.40 Cr · PAT ₹56.40 Cr.
Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.